Cases 1 - 4 of 4
UCB Pharma S.A. et al v. Nektar Therapeutics
as 1:2020cv00650
Plaintiff:
UCB Pharma S.A. and Celltech R&D Limited
Defendant:
Nektar Therapeutics
Cause Of Action: 28 U.S.C. § 1338
UCB, Inc. et al v. InvaGen Pharmaceuticals, Inc.
as 2:2015cv06919
Counter Claimant:
InvaGen Pharmaceuticals, Inc.
Counter Defendant:
InvaGen Pharmaceuticals, Inc.
Defendant:
InvaGen Pharmaceuticals, Inc.
Plaintiff:
UCB Pharma S.A. and UCB, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
UCB Pharma, S.A. v. Kappos
as 1:2013cv00117
Plaintiff:
UCB Pharma, S.A.
Defendant:
Hon. David J. Kappos
Cause Of Action: 35 U.S.C. § 154 AIA Appeal of Patent Term Adjustment Determination
PAR PHARMACEUTICAL, INC. v. UCB, INC. et al
as 2:2011cv02010
Plaintiff:
PAR PHARMACEUTICAL, INC.
Defendant:
UCB, INC. and UCB PHARMA S.A.
Cause Of Action: 35 U.S.C. § 145
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
